Background: Neurodevelopment requires thyroid hormone, yet the mechanisms and targets of thyroid hormone action during embryonic stages remain ill-defined. We previously showed that the thyroid hormone thyroxine (T4) rapidly increases voltage-gated sodium current in zebrafish Rohon-Beard cells (RBs), a primary sensory neuron subtype present during embryonic development. Here, we determined essential components of the rapid T4 signaling pathway by identifying the involved intracellular messengers, the targeted sodium channel isotype, and the spatial and temporal expression pattern of the nongenomic V3 integrin T4 receptor.
Background
Although thyroid hormone deficiency results in severe neurodevelopmental deficits [1] , the underlying mechanisms remain unclear. The traditional mechanism for thyroid hormone action involves conversion of secreted thyroxine (T4) to triiodothyronine (T3) by deiodination at the cellular level by target tissues. T3 then binds to intracellular nuclear thyroid hormone receptors to modulate transcription over a time course of hours to days [2, 3] . However, deletion of nuclear thyroid hormone receptors have little effect on development [4] , suggesting that either unliganded thyroid hormone nuclear receptors mediate the consequences of hypothyroidism [5] or nonnuclear thyroid hormone receptors remain functional.
Recent studies have shown that exogenously applied T3 and T4 can act through extranuclear plasma membrane receptors on a timescale of minutes [6] , providing a nongenomic mechanism for thyroid hormone signaling apart from traditional nuclear signaling. Bergh et al. [7] showed that the integrin dimer V3 acts in vivo as a nongenomic thyroid hormone receptor in the chick chorioallantoic membrane and that T4-V3 binding regulates angiogenesis. In addition, they found that V3 displayed a higher binding affinity for T4 over T3. The increased specificity for T4 supports the view that T4 acts as more than a prohormone to T3.
Integrins are present during nervous system development [8] and regulate neuronal migration [9] and apoptosis [10] . We previously reported that blockade of integrin V3 reduced voltage-gated sodium current in RohonBeard primary sensory neurons (RBs) [11] . Here, we focus on the intracellular pathways that translate T4-V3 signaling into modulation of sodium current (I Na ). Davis and colleagues [7, 12] demonstrated that T4 binding to integrin V3 activates the mitogen-activated protein kinase (MAPK) extracellular regulated kinase (ERK1/2) pathway. In addition, thyroid hormones can regulate other second messenger pathways, including the MAPK p38 isoform [13] and protein kinase C [14, 15] . The candidate intracellular messengers of rapid thyroid hormone signaling may regulate sodium channel function via phosphorylation.
One possible scenario is that the involved intracellular kinases and phosphatases directly regulate the phosphorylation state of a sodium channel. Consistent with this possibility, phosphorylation of voltage gated sodium channels by MAPK (p38) reduces I Na amplitude by 50% [16] . In the zebrafish embryo, MAPK (ERK1/2), MAPK (p38), and protein phosphatase (PP) subtypes PP1 and PP2A are all expressed in the spinal cord at 48 hours postfertilization (hpf) [17] , allowing for pharmacological assay of the effects of kinase and phosphatase inhibition on RB I Na and embryonic T4 signaling.
Regardless of whether phosphorylation directly targets sodium channels, our data indicate that rapid T4 signaling regulates sodium channel function. In RBs, two different types of sodium channels, Na v 1.1l and Na v 1.6a, carry I Na [18] . The contribution of the two channel types to RB I Na changes during development, with Na v 1.6a channels accounting for a majority of RB current at 48 hpf. We previously found I Na sensitivity to T4 at 48 hpf [11] , raising the possibility that T4 rapidly regulates Na v 1.6a channels. While Na v 1.6a is the major contributor to RB I Na , it is also widely expressed in the nervous system and is of critical importance to development [19] . T4 regulation of Na v 1.6a current would provide a mechanism for thyroid hormone to serve as an important developmental regulator of neural activity.
Here, we identify the signaling mechanisms and sodium channels underlying nongenomic T4 activity in embryonic zebrafish neurons. We also define the temporal and spatial expression pattern of the nongenomic T4 receptor, integrin V3, in zebrafish embryos. Our results indicate that neuronal cell types expressing both V3 and Na v 1.6a sodium channels respond rapidly to T4 with an increase in I Na amplitude.
Materials and methods
All experimental procedures were approved by the Animal Care and Use Committee of the Center for Comparative Medicine at the University of Colorado Denver -Anschutz Medical Campus.
Animals
Zebrafish (Danio rerio) adults were bred according to guidelines outlined in The Zebrafish Book [20] . Embryos were incubated at 28.5°C in embryo medium (130 mM NaCl, 0.5 mM KCl, 0.02 mM Na 2 HPO 4 , 0.04 mM KH 2 PO 4 , 1.3 mM CaCl 2 , 1.0 mM MgSO 4 , 0.4 mM NaH 2 CO 3 ) and staged according to external morphology [21] .
Electrophysiology
Whole cell voltage clamp recordings were obtained from zebrafish spinal cord RBs as previously described [11, 18, 22] . Voltage clamp recordings from caudal primary motoneurons (CaPs) were obtained from the Tg(hb9:GFP) line (gift of Drs Michael Fox and Joshua Sanes, Harvard University, Cambridge, MA, USA) that express green fluorescent protein (GFP) in motoneurons [23] . Tg(hb9:GFP) zebrafish were immobilized in Ringer solution (145 mM NaCl, 3 mM KCl, 1.8 mM CaCl 2 , and 10 mM HEPES, pH 7.2) containing 0.02% tricaine (Sigma St Louis, Missouri, USA) and glued laterally to glass cover-slips. Glass dissecting needles sufficed for removal of skin and detachment of overlying muscle fibers. Muscle fibers and secondary motoneurons were removed by a suction pipette to expose primary motoneurons. Three properties identified CaPs: GFP expression, cell body size (approximately 10 M diameter), and ventrally projecting axons [24] . For initial experiments, we used a reduced extracellular sodium bath solution (30 mM NaCl, 97 mM Nmethyl glucamine, 20 mM tetraethylammonium (TEA), 3 mM KCl, 2 mM CoCl 2 , and 10 mM HEPES) to reduce potential series resistance voltage errors arising from large I Na amplitudes. However, some experimental manipulations (for example, knockdown of sodium channel -subunits or phosphatase blockade) reduced I Na amplitudes; in these cases, we used a normal 125 mM extracellular sodium concentration to increase I Na amplitudes and the sensitivity of our measurements. Glass electrodes (2.0 to 3.5 MÙ) were filled with solution containing 10 mM NaCl, 135 mM CsCl, 10 mM EGTA, and 10 mM HEPES. We subtracted passive leak currents and capacitive transients from recordings of voltage-gated sodium using a P/ 8 protocol. Data were acquired using an Axopatch 200B amplifier (Axon Instruments, Foster City, California, USA) and analyzed with Clampfit8 (Axon Instruments) and Origin software (OriginLab, Northampton, Massachusetts, USA).
Data presentation
Results are presented as means ± standard errors. Statistical analysis was performed with Origin v7.0 software (OriginLab). Statistical comparisons of means were performed by one-way ANOVAs with Bonferroni corrections for multiple comparisons.
Hormone and drug application T4 (3,3',5,5'-tetraiodo-L-thyronine (thyroxine); Sigma) was prepared as a 30 mM stock solution in dimethyl sulfoxide (DMSO) that was diluted to final concentrations in extracellular recording solution immediately before use. Vehicle (DMSO) control experiments indicated that the final concentration of DMSO (0.001%) had no effect on I Na amplitudes; therefore, control and vehicle control data were pooled (Control/DMSO). Kinase and phosphatase inhibitors were applied to neurons in semi-intact preparations of the zebrafish embryo after obtaining control recordings prior to treatment. PD98059 (50 M; Sigma), 1 M SB203580 (Sigma), or okadaic acid (OA; 1 nM to 1 M; Sigma) was applied for 1 hour at room temperature before obtaining post-treatment recordings. The drugs remained in the bath during post-treatment recording.
Immunocytochemistry
Whole mount embryos (24 to 48 hpf) were processed for immunocytochemistry as previously described [25] . The primary antibody, mouse anti-human monoclonal LM609 (Millipore, Billerica, MA, USA), was diluted 1:100. Secondary antibody was applied overnight at 4°C (1:500; goat anti-mouse conjugated to Alexa 568; InvitrogenMolecular Probes, Carlsbad, California, USA). Controls consisted of experiments done with LM609 that had been previously incubated with 50 g/ml human V3 (Millipore). In some experiments, the Tg(isl3:GFP) line (gift of Drs Andrew Pittman and Chi-Bin Chien, University of Utah) expressing GFP in RBs or the Tg(hb9:GFP) line expressing GFP in motoneurons were used. GFP expression was revealed using a rabbit anti-GFP antibody conjugated to Alexa 488 (1:400; Invitrogen). For analysis, embryos were mounted in a 1% low melting point agarose solution and imaged using a Zeiss Pascal Confocal Microscope using 10× or 40× objectives and separate 488 and 568 laser lines. Fluorescent images were collected digitally as z-stacks of 2 m slices. Data are presented as projections of 20 to 25 slices.
Morpholino knock-down
Antisense oligonucleotide morpholinos (MOs) targeting sodium channels Na v 1.6a (1.6 MO) and Na v 1.1l (1.1 MO) were synthesized and prepared as previously described [18] . Injection solutions contained the dye Fast Green (1%) to report efficient delivery of the MO to animal cells. For each Na v 1 MO, control MOs were synthesized by introducing mismatches at five positions. Embryos that had either Na v 1.6a or Na v 1.1l sodium channel subunit knock-down were created by injection of 2 to 3 hpf wild-type embryos with solution containing 0.3 mM MO antisense oligonucleotide [18] . All MOs have been used previously and tested by standard control experiments [18, 19, 26] .
Embryos that had Fast Green within the animal cell 15 minutes post-injection were transferred to a petri dish containing embryo medium (130 mM NaCl, 0.5 mM KCl, 0.02 mM Na 2 HPO 4 , 0.04 mM KH 2 PO 4 , 1.3 mM CaCl 2 , 1.0 mM MgSO 4 , 0.4 mM NaH 2 CO 3 ) and then raised at 28°C until 48 hpf. Embryos that were injected with the 1.6 MO or 1.1 MO and selected for recording are referred to as Na v 1.6a or Na v 1.1l morphants, respectively.
Results
Blockade of either p38 MAPK or PP1 alters RB I Na amplitude and occludes the rapid T4 effect In other systems, rapid thyroid hormone signaling involves intracellular signaling kinase pathways such as MAPK (ERK1/2) and MAPK (p38) [7, 12, 13, [27] [28] [29] . To identify intracellular mediators of rapid T4 signaling in RBs, we used a pharmacological approach. We inhibited MAPK (ERK1/2) or MAPK (p38) signaling by using the blockers PD98059 or SB203580, respectively. In addition, because phosphatase effects oppose kinase action we used OA to block serine/threonine phosphatases. At low OA concentrations we blocked PP2A (1 to 20 nM OA) and at higher concentrations we blocked both PP2A and PP1 (1 M OA). After incubation of spinal cord preparations in conditions of kinase or phosphatase blockade, we tested for effects of kinase and phosphatase inhibitors on I Na amplitude, in the absence and presence of T4.
Control/DMSO cells displayed a I Na peak amplitude of 1,665 ± 116 pA (n = 23; Figure 1D ) and responded to acute T4 application with a 39 ± 5% increase in amplitude (n = 4; P < 0.05). To test for involvement of ERK1/2, we used PD98059 (50 M), a specific inhibitor of the ERK 1/ 2 pathway component MEK1 [30, 31] . By itself, PD98059 did not significantly alter I Na peak density (1,756 ± 217 pA; n = 16; P = 0.69) compared to control/DMSO ( Figure  1D ). Further, RBs exposed to PD98059 could still respond to T4 by rapidly increasing I Na amplitude (Figure 2A , C). Compared to control/DMSO cells, however, PD98059-treated cells showed a blunted response to T4 ( Figure 2C ).
Whereas the PD98059 results suggest that the ERK1/2 pathway may partially mediate the rapid effects of T4, the data do not implicate ERK1/2 signaling in tonic regulation of the number of available sodium channels. In contrast, nongenomic T4 signaling regulates both the rapid response to T4 as well as the tonic levels of available sodium channels in RBs [11] . Overall, the PD98059 results suggest minimal involvement of the ERK1/2 pathway in T4 regulation of RB I Na .
We next tested the contribution of the MAPK (p38) pathway that mediates rapid thyroid hormone signaling triggered by T3 [13] and regulates I Na density [16] . In contrast to blockade of the ERK1/2 pathway, pharmacological inhibition of the p38 pathway increased tonic I Na amplitudes (in the absence of exogenous T4) 1.48-fold (2458 ± 134 pA; n = 14; P < 0.05, ANOVA) ( Figure 1D ). Moreover, following SB203580 treatment, T4 no longer produced a rapid increase in I Na amplitude. In fact, after SB203580 treatment, T4 application led to a 22 ± 4% (n = 5) decrease in RB I Na amplitude (Figure 2A, C) . Overall, the effects of SB203580 support involvement of the p38 pathway in regulation of both the resting levels of available RB sodium channels as well as the rapid response of RB I Na to T4.
The SB203580 results suggest that T4 acts rapidly on RBs by opposing ongoing MAPK p38 signaling either by inhibiting the kinase or by activating relevant serine/threonine phosphatases. Two serine/threonine phosphatases, PP2A and PP1, are both ubiquitously expressed in the zebrafish spinal cord at 48 hpf [17] , a time when T4 rapidly regulates RB sodium current. To test for involvement of PP2A or PP1, we incubated zebrafish spinal cords with the serine/threonine phosphatase inhibitor OA prior to recording I Na from RBs. At concentrations of 1 to 20 nM, OA specifically inhibits PP2A. However, 1 and 20 nM OA did not significantly alter I Na peak amplitudes in the absence of T4 (1,761 ± 179 pA (n = 6) and 1,798 ± 283 pA (n = 11), respectively). In contrast, the IC 50 for PP1 inhibition by OA is much higher (approximately 0.5 M) [32] . OA at 1 M produced a drastic 90% reduction in resting RB I Na peak amplitudes (169 ± 33 pA; n = 7; P < 0.00001, ANOVA; Figure 1D ). Further, following 1 M OA treatment, T4 no longer increased RB I Na amplitude (-6 ± 4% change; n = 7; P = 0.98 versus no T4 added; Figure  2A , C). Both the tonic reduction in I Na peak amplitude and the occlusion of rapid T4 effects under conditions of PP1 blockade support the view that PP1 activity modulates RB I Na amplitudes.
Rapid T4 effects require sodium channel -subunit

Na v 1.6a
We tested whether T4's rapid action on RB I Na amplitude targeted a specific voltage-gated sodium channel isotype. RBs express two different sodium channel -subunit genes, scn1.1l and scn8aa, which code for the voltagegated sodium channel proteins Na v 1.1l and Na v 1.6a, respectively [33] . Interestingly, the conductance carried by the mammalian homologue of Na v 1.6a is significantly reduced by activation of MAPK p38 [16] . We knocked down either Na v 1.1l or Na v 1.6a using MOs, as done previously for effective and selective elimination of specific Na v 1 proteins in the zebrafish embryo [18, 19] .
As found previously, knockdown of either Na v 1.6a or Na v 1.1l -subunits led to decreased RB I Na peak amplitudes ( Figure 3D ) [18] . Further, injection of the control Na v 1.6a 5-missense MO did not significantly alter RB I Na peak density. We next tested whether knock-down of either sodium channel subunit prevented T4's rapid modulation of RB I Na by acute application of T4 to morphant embryos. We found that T4 increased RB I Na amplitude in control morphants (45 ± 8%; P < 0.05 versus no hormone) to a similar extent as in wild-type embryos (39 ± 5%) [11] (Figure 3A , E). However, in Na v 1.6a morphants, T4 application did not increase I Na amplitudes (-16 ± 5%; P < 0.05 versus control morphants), indicating that rapid T4 action targets Na v 1.6a channels.
In contrast, in Na v 1.1l morphant embryos, T4 application increased RB I Na (63 ± 10%; P < 0.05 versus no hormone), suggesting that T4 does not require Na v 1.1l channels to increase RB I Na density. In Na v 1.1l morphants, the increase in I Na amplitude induced by T4 actually exceeded that produced in controls (63 ± 10% versus 45 ± 8%; P < 0.05), presumably because Na v 1.6a channels carry the majority if not all of the remaining current [18] . The effects of T4 on Na v 1.6a and Na v 1.1la morphants indicate that rapid T4 signaling targets Na v 1.6a sodium channels. To block relevant kinase pathways, we incubated the exposed zebrafish spinal cord preparation in the indicated inhibitors for 1 hour prior to recording I Na peak amplitudes. We blocked two separate kinase pathways, ERK1/2 and p38, with the inhibitors PD98059 and SB203580, respectively. In order to block protein phosphatase (PP) activity, we used two different okadaic acid (OA) concentrations that inhibit either PP2A only (1 to 20 nM), or both PP2A and PP1 (1 M). (B) After a 1 hour incubation in SB203580, RB I Na peak amplitude increased. Conversely, 1 M OA decreased RB I Na peak amplitude. (C) Average current-voltage (I-V) relationships for I Na recorded after p38 and PP1 inhibition showed changes in I Na amplitude without alteration of the reversal potential (E rev ). p38 inhibition (n = 14) led to an increase in I Na amplitude compared to controls (n = 23). In contrast, phosphatase inhibition with 1 M OA (n = 7) reduced I Na compared to controls. Neither treatment affected E rev . (D) Peak I Na amplitudes of cells exposed to the ERK1/2 inhibitor PD98059 (n = 16) did not significantly change I Na peak amplitude compared to controls (n = 23). However, incubation of zebrafish embryos in the p38 inhibitor SB203580 (n = 14) significantly increased I Na peak amplitude (P < 0.05; ANOVA). Inhibition of PP2A (1 and 20 nM OA; n = 6 and 11, respectively) did not significantly change peak I Na amplitude compared to controls. However, 1 M OA (n = 7), which inhibits both PP2A and PP1, resulted in a significant reduction in I Na peak amplitude (P < 0.05; ANOVA). Asterisks represent a p-value of < 0.05 and error bars represent standard errors.
Antagonists of nongenomic thyroid hormone signaling do not affect RB I Na in Na v 1.6a morphants Antagonists of thyroid hormone (3,3',5,5'-tetraiodothyroacetic acid (tetrac)) or of the integrin V3 block rapid T4 signaling in RBs [11] . We next tested whether the effects of thyroid hormone antagonism or V3 blockade targeted Na v 1.6a-mediated current. We exposed Na v 1.6a morphants to the thyroid hormone analog tetrac, or the V3 function blocking antibody LM609. To more readily detect changes in RB I Na amplitude in Na v 1.6a morphants, we raised the extracellular sodium concentration to 125 mM to increase I Na amplitudes. We previously showed PD98059 treatment (n = 6) did not significantly affect T4's increase in peak INa amplitude compared to controls. However, SB203580 (n = 5) or OA (n = 3) treatments prevented a rapid increase in INa amplitude (P < 0.05; ANOVA) in response to acute T4 application. The data presented were acquired in the presence of 125 mM extracellular Na+. Asterisks represent a pvalue of < 0.05 and error bars represent standard errors.
that tetrac reduces RB I Na amplitudes in wild-type embryos [11] . However, in Na v 1.6a morphants, tetrac did not significantly change RB I Na amplitudes compared to Na v 1.6a morphants unexposed to tetrac ( Figure 3F) . We had also previously demonstrated that LM609 reduced RB I Na amplitudes by 46% in wild-type embryos [11] . In contrast, in Na v 1.6a morphants, LM609 injection did not significantly affect I Na peak amplitudes compared to Rohon-Beard cells in Na v 1.6a morphants did not show a rapid T4 response Figure 3 Rohon-Beard cells in Na v 1.6a morphants did not show a rapid T4 response. (A-C) The representative traces show Rohon-Beard cell (RB) I Na before (black) and 5 minutes after (red) acute T4 application. Embryos had been injected with either the 1.6 missense control morpholino (Ctl MO) (A), or MOs targeting sodium channels Na v 1.1l (1.1 MO) or Na v 1.6a (1.6 MO) (C). (D) Injection of 1.6 MO or 1.1 MO reduced RB I Na peak amplitude compared to control. The reductions in I Na peak amplitudes were consistent with previously reported values for successful knockdown of either Na v 1.6a or nav1.1la [18] . Injection of 5-missense control MO did not significantly alter I Na peak amplitude. The data presented in (D) were recorded in the presence of 30 mM extracellular Na + . (E) Embryos injected with 5-missense MO or 1.1 MO showed significant increases in RB I Na peak amplitude after 5 minutes of T4 application. In contrast, RBs in 1.6 morphant embryos did not show an increase in I Na amplitude after T4 application. (F) Injection of 1.6 MO (n = 3) reduced peak I Na amplitude in 125 mM extracellular recording solution compared to controls (n = 5; P < 0.05). In control embryos, thyroid hormone antagonism (tetrac) or V3 blockade (LM609) injection reduced I Na amplitudes [11] . However, in 1.6 morphant embryos, neither LM609 (n = 5) nor tetrac (n = 9) altered I Na amplitudes compared to 1.6 morphants unexposed to LM609 or tetrac (n = 3). Asterisks represent a p-value of < 0.05 and error bars represent standard errors.
uninjected Na v 1.6a morphants ( Figure 3F ). The lack of effect of either tetrac or LM609 in Na v 1.6a morphants further supports that the rapid T4-integrin signaling pathway specifically targets Na v 1.6a channels.
Developmental regulation of V3 expression temporally restricts T4 signaling in RBs
Whether T4 induced increases in sodium current occur throughout development or if T4 signaling begins at a defined developmental stage is unknown. The above results combined with our previous study [11] indicate that in order to respond rapidly to T4 at 48 hpf, RBs require integrin V3 and the Na v 1.6a sodium channel -subunit. We next determined whether V3 is present and if RBs respond rapidly to T4 at earlier stages. We reasoned that absence of integrin V3 would prevent T4 from rapidly modulating RB I Na . Accordingly, we tested our prediction by determining the spatial and temporal V3 expression pattern.
To determine when RBs express the plasma membrane T4 receptor, we performed immunocytochemistry using the LM609 antibody that specifically detects the V3 dimer [34] . As expected, at 48 hpf the LM609 antibody revealed immunoreactivity in dorsal spinal cord cells ( Figure 4A ) and cells in the ventral spinal cord. However, at 24 hpf, no immunoreactivity was detected ( Figure 4B ). To test whether immunoreactivity was specific for V3, we preZebrafish embryos expressed integrin V3 at 48 hpf but not at 24 hpf incubated LM609 with integrin V3 protein prior to zebrafish application. We found pre-incubation of LM609 with V3 protein prevented detection of immunoreactivity ( Figure 4C ), indicating specificity of immunostains for V3.
LM609 immunoreactive cells localized to the dorsal spinal cord where RBs reside. To identify LM609 immunoreactive cells as RBs, we used transgenic Tg(isl3:GFP) embryos. In this line, the isl3 promoter drives GFP expression in RBs (A Pittmann and Chi-Bin Chien, personal communication). In 48 hpf Tg(isl3:GFP) embryos ( Figure  4D-F) , LM609 immunoreactivity colocalized with GFP, revealing V3 expression on RB bodies. This result is consistent with rapid V3-dependent T4 signaling in 48 hpf RBs [11] . In contrast, at 24 hpf, zebrafish embryos did not show specific LM609 immunolabeling in either the dorsal or ventral spinal cord ( Figure 4B ). These data indicate that V3 dimers appear on RBs after 24 hpf.
At 24 hpf, Na v 1.6a underlies a portion of RB I Na [18] . Nonetheless, according to our model, the lack of V3 expression on RBs at 24 hpf would prevent T4 from rapidly modulating RB I Na To test this prediction, we acutely applied 30 nM T4 to the spinal cords of 24 hpf embryos and recorded RB I Na . In contrast to results obtained from 48 hpf embryos [11] , we found that T4 had no significant effect on RB I Na amplitude at 24 hpf ( Figure 5A, B) . These results indicate that acute modulation of RB I Na requires V3.
T4 rapidly increases sodium current density in CaPs
As another test of the requirement for integrin V3, MAPK p38/PP1, and the Na v 1.6a sodium channel -subunit for rapid T4 signaling, we sought to identify another neuronal cell type that expressed these critical components and test whether T4 could also rapidly modulate I Na amplitude. The intracellular messengers are ubiquitously expressed in the zebrafish spinal cord [17] , and several ventral spinal cord neurons, including interneurons and motoneurons, express Na v 1.6a [19, 33] . We detected LM609 immunoreactivity in the ventral spinal cord (Figure 4A ) and now determined the identity of these neurons by using the Tg(hb9:GFP) line. In Tg(hb9:GFP) embryos, motoneurons express GFP, allowing morphological assessment of cell bodies and axonal projections [23] . At 48 hpf, a subset of GFP expressing cells in Tg(hb9:GFP) embryos were also immunoreactive for LM609 ( Figure  6A-C) . In particular, ventral neurons with large diameter cell bodies, a hallmark of primary motoneurons, were copositive for GFP and LM609 ( Figure 6B, C) . At 48 hpf, the spinal cord contains three different types of primary motoneurons [24] . One primary motoneuron, CaP, expresses Na v 1.6a at 48 hpf [19, 33] . Because rapid T4 modulation of I Na targets Na v 1.6a, co-expression of Na v 1.6a and integrin V3 raised the possibility that CaPs might respond to T4 with a rapid increase in I Na amplitude. To test this possibility, we applied 30 nM T4 to CaP motoneurons, identified in Tg(hb9:GFP) 48-hpf embryos by cell body size and ventrally projecting axons, while recording I Na . In control CaP recordings, I Na peak density decreased over 5 minutes by 7 ± 2%. However, CaP I Na density significantly increased by 28 ± 8% (P < 0.005) after acute T4 application (Figure 6D-F) . These results support our model that rapid regulation of I Na density by T4 requires V3 and targets Na v 1.6a channels.
Discussion
Summary
Our results identify messengers and targets of a rapid thyroid hormone signaling pathway that functions in the zebrafish embryonic nervous system. The T4 pathway rapidly induces increased sodium current amplitudes and requires the sodium channel isotype Na v 1.6a even though neurons express several different sodium channel isotypes. Moreover, the results suggest that the phosphorylation state of an involved protein, perhaps even the targeted sodium channel isotype, determines sodium channel activity.
Signaling pathway
We propose a model in which the phosphorylation status of a particular protein or set of proteins regulates RB I Na amplitude, and T4 rapidly alters the phosphorylation status of relevant protein(s). Further, the data suggest that serine/threonine phosphorylation and dephosphorylation reduce and increase, respectively, RB I Na amplitude. To increase RB I Na amplitude, T4 may rapidly activate PP1 and/or inhibit p38. Consistent with our findings, PP1 modulates I Na amplitudes in rat striatal neurons [35] , which express Na v 1.6 [36] . Schiffmann et al. [35] found that PP1 blockade reduced rat striatal I Na amplitudes, similar to our results in zebrafish RBs.
Our data do not provide information about the identity of the phosphorylated protein(s). One possibility is that T4 binding to V3 activates intracellular pathways that directly phosphorylate sodium channel -subunits. In ND7/23 cells transfected with mammalian Na v 1.6 sodium channels, activation of p38 produces a decrease in I Na [16] . Of particular relevance, biochemical analysis demonstrated that p38 activity regulated phosphorylation of a specific Na v 1.6 serine, S553, revealing the Na v 1.6 sodium channel as a direct p38 phosphorylation target [16] . On this basis, the RB T4-V3 pathway may modulate I Na by regulating the phosphorylation state of the conserved serine residue in zebrafish Na v 1.6a.
T4 did not affect Rohon-Beard cell sodium current amplitude at 24 hpf Figure 5 T4 did not affect Rohon-Beard cell sodium current amplitude at 24 hpf. (A) The 24 hpf zebrafish embryos were tested for the ability of Rohon-Beard cells (RBs) to respond rapidly to T4. I Na peak amplitudes did not significantly change over 5 minutes of T4 application. In the representative recording, I Na was elicited by a depolarizing voltage step to -10 mV from a holding potential of -80 mV. (B) At 24 hpf, 30 nM T4 application did not significantly alter RB I Na (n = 6) compared to controls (n = 4). In contrast, when V3 is expressed in the spinal cord at 48 hpf, T4 acutely increased RB I Na (48 hpf data from [11] ). T4 increases sodium current in caudal primary motoneurons One result that the model does not fully account for, however, is the large reduction in RB I Na amplitude produced by PP1 inhibition. We previously reported that either T4 or V3 blockade reduced I Na by only 50%, yet 1 M OA reduced RB I Na by nearly 90%. This discrepancy could be attributed to different degrees of PP1 inhibition by 1 M OA versus T4/V3 blockade. The large decrease in I Na amplitude produced by 1 M OA could also reflect phosphorylation effects triggered by non-T4-dependent mechanisms. For example, protein kinases C and A also have effects on Na v 1.6 amplitude [37] .
V3 acts as a T4 receptor in the nervous system
The important developmental roles of integrins as cell surface adhesion proteins have been well studied [8] . Lesswell studied, however, is the potential role of integrins as receptors for hormones. Because neurons and glia [38] express V3, nongenomic T4 signaling via V3 may play an important role in nervous system development.
Here, we focused on integrin's role as a plasma membrane receptor for thyroid hormones that traditionally signal through nuclear receptors. We focused on the integrin dimer, V3, a protein that is important for neuronal migration and axon extension [39] [40] [41] , and is expressed on dorsal root ganglia [42, 43] . The fact that RGD (AspGly-Arg) proteins block rapid T4 signaling mediated by V3 [7] suggests that the hormone interacts with the RGD recognition site [44] . Davis et al. suggested that, in addition to V3, seven other RGD integrin dimers may function as thyroid hormone receptors [28] .
In addition to T4, the iodothyronine T3 binds to integrin V3 and activates both ERK1/2 and phosphatidyl inositol 3-kinase [45] . If T3 interacts with RB V3 to activate ERK1/2 and phosphatidyl inositol 3-kinase, our data indicate that activation of these signaling pathways has no effect on RB I Na amplitude. Although we found that T3 does not affect RB I Na , previous studies show T3 can increase I Na depending on cell type. For example, chronic T3 application increases I Na in cultured rat hippocampal neurons [46] , but not rat cortex in vitro. This result was attributed to increased nuclear thyroid hormone receptor expression in hippocampus versus cortex leading to differential genomic regulation of sodium channel expression. Additionally, T3 rapidly increases I Na in cultured myocytes [47, 48] through mechanisms that involve rises in intracellular calcium [48] and protein kinase C [47] . Altogether, both T4 and T3 nongenomic signaling result in a variety of downstream consequences due to the diversity of signaling mechanisms activated by plasma membrane thyroid hormone receptors.
Implications of rapid T4 targeting of Na v 1.6a and importance to the nervous system During intrauterine stages, the human embryo requires maternally provided thyroid hormone for normal development [49] [50] [51] . However, the specific roles and underlying mechanisms of thyroid hormone action during embryogenesis are poorly understood. Thyroid hormone signals nongenomically to regulate migration of neural cells in the embryonic nervous system [52] . Our data indicate that thyroid hormone, acting rapidly via a plasma membrane receptor, shapes emerging properties of neuronal excitability. Specifically, thyroid hormone rapidly modulates neuronal sodium current by targeting the Na v 1.6a subunit. The implications for mammals are substantial because the mammalian homologue, Na v 1.6, shows widespread expression in both the central and peripheral nervous systems [53, 54] and is highly expressed during embryonic stages [55] . Moreover, Na v 1.6a plays important developmental roles for sensory neuron survival and motoneuron axon growth in zebrafish [19, 25] . Taken together, these findings indicate that modulation of Na v 1.6 current during embryonic stages serves as a strategic way to regulate both structural and functional development of the nervous system.
In the context of our results, periods of thyroid hormone deprivation during development would decrease sodium current in neurons expressing both V3 and Na v 1.6, leading to reduced excitability. Conversely, an excess of thyroid hormone would increase sodium current and potentially induce pathological hyperexcitability, associated with seizures and developmental abnormalities. Interestingly, increased expression of Na v 1.6 channels are associated with epileptogenesis in mouse hippocampal neurons through mechanisms of enhanced excitability [56] , and acute increases in T4 have been reported to cause seizures in humans [57] . Also of note, mice without the functional sodium channel gene SCN8A are somewhat resistant to seizures [58] and children with congenital hypothyroidism have a significantly reduced incidence of febrile convulsions [59] . Whether thyroid hormone can acutely influence seizure activity through V3-dependent regulation of Na v 1.6 in mammals warrants further study. Altogether, T4 regulation of Na v 1.6a current provides an important mechanism to influence neuronal activity and development.
We focused on rapid T4 signaling in the embryonic nervous system. However, V3 and Na v 1.6 are also present in the adult nervous system, raising the possibility that T4 acutely regulates sodium current in adults. During adult stages, Na v 1.6 is the primary sodium channel isoform expressed at nodes of Ranvier [53] . T4 induced modulation of Na v 1.6 mediated current would alter I Na at nodes of Ranvier and, therefore, regulate axonal conductance.
The mechanism of thyroid hormone action on adult neurons is unclear, yet alterations in Na v 1.6 current could result in deficits in sensory neuron axonal conductance and could account for states of hyper-or hypo-reflexia observed in hyper-or hypothyroid patients, respectively [60, 61] . Studies on T4-V3's activation of angiogenesis and tumor cell proliferation also have clinical corollaries in adults as hypothyroid states reduce tumor cell proliferation in gliomas [62] .
Conclusion
Our results delineate a pathway for rapid T4 signaling that is initiated by V3 as a T4 receptor, transduced intracellularly by regulation of phosphorylation states, and targets the Na v 1.6a sodium channel -subunit. Our proposed pathway predicts that T4's rapid modulation of sodium current requires expression of both V3 and Na v 1.6a on the responding cell. Our data agree with the prediction in three ways. First, in RBs, T4 rapidly increased sodium current amplitudes at 48 but not 24 hpf, consistent with detection of V3 at 48 but not 24 hpf. Second, upon knock-down of Na v 1.6a protein, exogenously applied T4 no longer led to a rapid increase in RB I Na amplitude. Third, another neuronal population, CaP, which expresses both V3 and Na v 1.6a, responded to T4 with a rapid increase in I Na amplitude. Uncovering the signaling pathways and relevant proteins involved in nongenomic T4 signaling contributes to our understanding of how thyroid hormone regulates development and function of the nervous system.
